Denosumab
| Use attributes for filter ! | |
| Formula | C6404H9912N1724O2004S50 |
|---|---|
| Molar mass | 144. 7 kg/mol g·mol−1 |
| Other names | AMG 162 |
| Trade name | Prolia, Xgeva |
| Target | RANK ligand |
| Metabolism | proteolysis |
| Music groups | Zoledronic acid |
| Teriparatide | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951100 |
About Denosumab
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Denosumab is contraindicated in people with low blood calcium levels. The most common side effects are joint and muscle pain in the arms or legs.